轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體
Monoclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
TGF-B3; LAP; Latency-associated peptide
- 編號(hào)UMAB949Hu24
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來(lái)源單抗制備
- 宿主小鼠
- 效價(jià)(克隆號(hào))C5
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無(wú)標(biāo)記物
- 免疫原 RPB949Hu02-轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應(yīng)用WB; IHC; ICC/IF
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 317 ¥ 739 ¥ 1056 ¥ 2640 ¥ 10560
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Lung cancer Tissue; Primary Ab: 20μg/ml Mouse Anti-Human TGFb3 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
FITC staining on IF;<br/>Samples: Human MCF7 cell; <br/>Primary Ab: 20μg/ml Mouse Anti-Human TGFb3 Antibody<br/>Second Ab: 0.75μg/ml FITC-Linked Caprine Anti-Mouse IgG Polyclonal Antibody<br/>(Catalog: SAA544Mu18)
-
AF488 staining on IF;
Sample: HepG2 cell
Primary Ab: 20μg/ml Mouse Anti-Human TGFb3 Antibody
Second Ab: 2μg/ml AF488-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu11)
-
Figure. Western Blot; Sample: Recombinant TGFb3, Human.
-
Western Blot; Sample: Human MCF7 cell lysate;
Primary Ab: 3μg/ml Mouse Anti-Human TGFb3 Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)TGFb3的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別TGFb3。
用法
Western blotting: 0.01-3μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPB949Hu02 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPB949Hu02 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPB949Hu01 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPB949Hu61 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB949Hu03 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPB949Hu01 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)活性蛋白 | Cell?culture;?Activity?Assays. |
| UPAB949Hu01 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)多克隆抗體 | IHC |
| UPAB949Hu02 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)多克隆抗體 | IHC; ICC/IF |
| ULAB949Hu71 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| UMAB949Hu23 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體 | IHC; ICC/IF |
| URAB949Hu21 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
| UMAB949Hu22 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體 | WB |
| UMAB949Hu24 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體 | WB; IHC; ICC/IF |
| UMAB949Hu26 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體 | ICC/IF |
| UMAB949Hu25 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體 | ICC/IF |
| UMAB949Hu21 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體 | WB; IHC; ICC/IF |
| USEB949Hu | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCB949Hu | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMB949Hu | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UPSB949Hu01 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| UKSB949Hu01 | 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| PLoS ONE | A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches [Plosone: Source] |
| J Reprod Immunol | The immunomodulating effect of seminal plasma on T cells [PubMed: 25799173] |
| Fertility and Sterility | Influence of vitamin D and transforming growth factor β3 serum concentrations, obesity, and family history on the risk for uterine fibroids [pubmed:27743697] |
| Eur J Pharm Biopharm | New scaffolds encapsulating TGF-β3/BMP-7 combinations driving strong chondrogenic differentiation [pubmed:28087378] |
| Transforme edici büyüme fakt?rü-beta-1 n?tralizan antikoru ve transforme edici büyüme fakt?rü-beta-3'ün trakeal darl?k geli?imi üzerine etkileri [10.5606/tgkdc.dergisi.2017.14302] | |
| Fertility and Sterility | Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids [Pubmed:29525690] |
| Scientific Reports | TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration [Pubmed:29795291] |
| Immunology?Letters | The involvement of multifunctional TGF-β and related cytokines in pathogenesis of endometriosis [Pubmed: 30367890] |
| Cell?Reports | Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue [Pubmed: 30332637] |
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | Temporal TGF-β Supergene Family Signalling Cues Modulating Tissue Morphogenesis: Chondrogenesis within a Muscle Tissue Model? [Pubmed: 32660137] |
| Equine Vet J | Limited added value of negative pressure wound therapy compared to calcium alginate dressings for second intention healing in a non?\contaminated and??- [34115409] |
| AAPS PharmSciTech | Nanoparticles and Nanostructured Films with TGF-β3: Preparation, Characterization, and Efficacy [34378118] |
留言咨詢
